Stratec SE (SBS.DE) Stock

Healthcare · Medical Devices · Member of SDAX

Stratec SE (SBS.DE) closed at EUR 24.20 on 2026-10-15, a change of +0.5 % over the past year, with a market capitalization of EUR 287.49M.

Stratec SE recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Stratec SE key figures

Previous close

EUR 24.20 (2026-10-15)

1-year change

+0.5 %

Market cap

EUR 287.49M

Enterprise value

EUR 384.18M

P/E ratio (trailing)

-788.33

P/E ratio (forward)

13.61

EPS (trailing)

-0.03

EPS (forward)

1.74

PEG ratio

0.98

Price to book

1.21

Revenue growth

1.5 %

Earnings growth

277.8 %

Dividend per share (trailing)

0.60

Short ratio

n/a

Employees

1,383

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Stratec SE and compare it with other stocks.